Phase II study of dose-adjusted EPOCH-R in untreated de novo CD20+ diffuse large B-cell lymphoma (DLBCL)-CALGB 50103.

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Wilson, WH; Porcu, P; Hurd, D; Martin, SE; Czuczman, M; Niedzwiecki, D; Saint Louis, JD; Johnson, JL; Cheson, B; Canellos, GP; Zelenetz, AD

Published Date

  • June 1, 2005

Published In

Volume / Issue

  • 23 / 16

Start / End Page

  • 567S - 567S

Published By

Pages

  • 1

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Conference Name

  • 41st Annual Meeting of the American-Society-of-Clinical-Oncology

Conference Location

  • Orlando, FL

Conference Start Date

  • May 13, 2005

Conference End Date

  • May 17, 2005